Cited by 2,641Clostridium difficile and Clostridium perfringens researchInfection Control in HealthcareAntimicrobial Resistance in Staphylococcus

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Burden of Clostridium difficile Infection in the United States

Open access

Lessa, Fernanda C., Mu, Yi, Bamberg, Wendy M., Beldavs, Zintars G., Dumyati, Ghinwa K., Dunn, John R., Farley, Monica M., Holzbauer, Stacy M., Meek, James I., Phipps, Erin C., Wilson, Lucy E., Winston, Lisa G., Cohen, Jessica A., Limbago, Brandi M., Fridkin, Scott K., Gerding, Dale N., McDonald, L. Clifford·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1408913PMC PMC10966662

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The magnitude and scope of Clostridium difficile infection in the United States continue to evolve. METHODS: In 2011, we performed active population- and laboratory-based surveillance across 10 geographic areas in the United States to identify cases of C. difficile infection (stool specimens positive for C. difficile on either toxin or molecular assay in residents ≥ 1 year of age). Cases were classified as community-associated or health care-associated. In a sample of cases of C. difficile infection, specimens were cultured and isolates underwent molecular typing. We used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection. RESULTS: A total of 15,461 cases of C. difficile infection were identified in the 10 geographic areas; 65.8% were health care-associated, but only 24.2% had onset during hospitalization. After adjustment for predictors of disease incidence, the estimated number of incident C. difficile infections in the United States was 453,000 (95% confidence interval [CI], 397,100 to 508,500). The incidence was estimated to be higher among females (rate ratio, 1.26; 95% CI, 1.25 to 1.27), whites (rate ratio, 1.72; 95% CI, 1.56 to 2.0), and persons 65 years of age or older (rate ratio, 8.65; 95% CI, 8.16 to 9.31). The estimated number of first recurrences of C. difficile infection was 83,000 (95% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100). The North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care-associated infections than among community-associated infections (30.7% vs. 18.8%, P<0.001). CONCLUSIONS: C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011. (Funded by the Centers for Disease Control and Prevention.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1408913

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Self-citation
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pépin, J., & Wilcox, M. H. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,931
Self-citation
Sampling: Design and Analysis
Ziegel, E. R., & Lohr, S. L. (2000) · Technometrics · doi:10.2307/1271491 · Cited by 2,452
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G., Thompson, A. D., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,020
Self-citation
A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M., Michaud, S., Bourgault, A., Nguyen, T., Frenette, C. H., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,962
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., BENTHEM, B. H. B. V., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,049
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, A., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 838
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R. P., Gerding, D. N., Nichol, G. M., Thomas, W. D., Leney, M. D., Sloan, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 743
Self-citation
Burden of Clostridium difficile on the Healthcare System
Dubberke, E. R., & Olsen, M. A. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis335 · Cited by 566
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
Planche, T., Davies, K., Coen, P. G., Finney, J. M., Monahan, I. M., Morris, K. A., O’Connor, L., Oakley, S. J., Pope, C. F., Wren, M. W. D., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70200-7 · Cited by 436

Flagged first, then by citations

Show all 44 references

Research works printed but not linked: 4

2005, MMWR Morb Mortal Wkly Rep, 54, 1201
Heitjan DF, 1991, J R Stat Soc Ser C Appl Stat, 40, 13
2014, Fed Regist, 79, 10524
2011, Fed Regist, 76, 51476

Sorted by citations

Items 901–1,000 of 1,002

Impact of a national antimicrobial stewardship mentoring program: Insights and lessons learned
Goff, D. A., Karam, G. H., & Haines, S. T. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160379 · Cited by 22
PCR-ribotype distribution of Clostridium difficile in Irish pigs
Stein, K., Egan, S. A., Lynch, H., Harmanus, C., Kyne, L., Herra, C. M., McDermott, S., Kuijper, E. J., Fitzpatrick, F., FitzGerald, S. F., et al. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.10.004 · Cited by 22
Clostridium difficile infection: a review
Kouhsari, E., Abbasian, S., Sedighi, M., Yaseri, H. F., Nazari, S., Bialvaei, A. Z., Dahim, P., Mirzaei, E. Z., & Rahbar, M. (2018) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000135 · Cited by 22
A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against Clostridium difficile
Thanissery, R., Zeng, D., Doyle, R. G., & Theriot, C. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01206 · Cited by 22
Hospital-Acquired Infections in Critically Ill Patients With Cancer
Battaglia, C. C., & Hale, K. E. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618788019 · Cited by 22
Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge
Reveles, K. R., Dotson, K. M., Gonzales-Luna, A. J., Surati, D., Endres, B. T., Alam, M. J., & Garey, K. W. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy782 · Cited by 22
An Engineered Synthetic Biologic Protects Against Clostridium difficile Infection
Vedantam, G., Kochanowsky, J. A., Lindsey, J., Mallozzi, M., Roxas, J. L., Adamson, C. C., Anwar, F., Clark, A. E., Claus-Walker, R. A., Mansoor, A., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02080 · Cited by 22
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection WithClostridium difficile
Lukin, D. J., Lawlor, G. O., Hudesman, D. P., Durbin, L. L., Axelrad, J. E., Passi, M., Cavaliere, K., Coburn, E. S., Loftus, M., Jen, H., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy308 · Cited by 22
Microbiomes as companion species: an exploration of dis- and re-entanglements with the microbial self
Beck, A. (2019) · Social & Cultural Geography · doi:10.1080/14649365.2019.1593490 · Cited by 22
Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population
Misch, E. A., & Safdar, N. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.02.010 · Cited by 22
Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy
Koya, S. K., Yurgelevic, S. M., Brusatori, M., Huang, C., Diebel, L. N., & Auner, G. W. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.06.039 · Cited by 22
Non-antibiotic therapy forClostridioides difficileinfection: a review
Yang, J., & Yang, H. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1648377 · Cited by 24
Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn’s Disease
Hellmann, J., Andersen, H. M., Fei, L., Linn, A., Bezold, R., Lake, K., Jackson, K., Meyer, D., Dirksing, K., Bonkowski, E. L., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz263 · Cited by 22
Clostridioides difficile Binary Toxin Is Recognized by the Toll-Like Receptor 2/6 Heterodimer to Induce a Nuclear Factor-κB Response
Simpson, M. D., Frisbee, A. L., Kumar, P., Schwan, C., Aktories, K., & Petri, W. A. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa620 · Cited by 22
Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics
Kociolek, L. K. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00147-17 · Cited by 22
Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?
Bassotti, G., Macchioni, L., Corazzi, L., Marconi, P., & Fettucciari, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2736-1 · Cited by 22
Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis
Reveles, K. R., Yang, M., García-Horton, V., Edwards, M. L., Guo, A. X., Lodise, T. P., Bochan, M. R., Tillotson, G., & Dubberke, E. R. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02498-x · Cited by 21
Causal role of the gut microbiome in certain human diseases: a narrative review
Prosty, C. J., Katergi, K., Papenburg, J., Lawandi, A., Lee, T. C., Shi, H., Burnham, P., Swem, L. R., Routy, B., Yansouni, C. P., et al. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100086 · Cited by 22
Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027
Kociolek, L. K., & Gerding, D. N. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02340-15 · Cited by 21
Self-citation
Online continuing interprofessional education on hospital-acquired infections for Latin America
Presentado, J. C. M., Margolis, Á., Teixeira, L. M., Lorier, L., Gales, A. C., Pérez-Sartori, G., de Oliveira, M. S., Seija, V., Paciel, D., Vignoli, R., et al. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.11.003 · Cited by 21
Among inpatients, ischemic bowel disease predisposes to Clostridium difficile infection with concomitant higher mortality and worse outcomes
Adejumo, A., Akanbi, O. H., & Pani, L. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001273 · Cited by 21
Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia
Alzouby, S., Baig, K. M., Alrabiah, F. A., Shibl, A. M., Al-Nakhli, D. J., & Senok, A. C. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.10.014 · Cited by 21
Novel and emerging sources of Clostridioides difficile infection
Turner, N., Smith, B. A., & Lewis, S. S. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008125 · Cited by 21
Characterization of Exosporium Layer Variability of Clostridioides difficile Spores in the Epidemically Relevant Strain R20291
Pizarro‐Guajardo, M., Calderón-Romero, P., Romero-Rodriguez, A., & Paredes‐Sabja, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01345 · Cited by 21
A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis
Esposito, G., Corpetti, C., Pesce, M., Seguella, L., Annunziata, G., Re, A., Vincenzi, M., Lattanzi, R., Lu, J., Sanseverino, W., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.639728 · Cited by 21
Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study
Azimirad, M., Jo, Y., Kim, M.-S., Jeong, M., Shahrokh, S., Aghdaei, H. A., Zali, M. R., Lee, S., Yadegar, A., & Shin, J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s338212 · Cited by 21
Any Future for Faecal Microbiota Transplantation as a Novel Strategy for Gut Microbiota Modulation in Human and Veterinary Medicine?
Takáčová, M., Bomba, A., Tóthová, C., Micháľová, A., & Turňa, H. (2022) · Life · doi:10.3390/life12050723 · Cited by 24
Reimagining Infection Control in U.S. Nursing Homes in the Era of COVID-19
Crnich, C. J. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.10.022 · Cited by 22
Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides difficile Infection in the USA
Lodise, T. P., Guo, A. X., Yang, M., Cook, E. E., Song, W., Yang, D., Wang, Q., Zhao, A., & Bochan, M. R. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02505-1 · Cited by 21
Trends in the epidemiology of Clostridioides difficile infection in Germany
Vehreschild, M. J. G. T., Schreiber, S., von Müller, L., Epple, H., Weinke, T., Manthey, C. F., Oh, J. S., Wahler, S., & Stallmach, A. (2023) · Infection · doi:10.1007/s15010-023-02044-5 · Cited by 21
Fecal microbiota transplantation for recurrent Clostridium difficile infection: The patient experience
Pakyz, A. L., Moczygemba, L. R., VanderWielen, L. M., & Edmond, M. B. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2016.01.018 · Cited by 21
Risk factors for short‐ and long‐term mortality in very old patients with Clostridium difficile infection: A retrospective study
Weissman, Y. L., Atamna, A., Schlesinger, A., Eliakim‐Raz, N., Bishara, J., & Yahav, D. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12866 · Cited by 21
Risk factors and epidemiology of C lostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period
Aldrete, S. D. M., Kraft, C. S., Magee, M. J., Chan, A. W., Hutcherson, D., Langston, A. A., Greenwell, B. I., Burd, E. M., & Friedman‐Moraco, R. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12649 · Cited by 21
Phase 1 Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor, in Healthy Subjects
Vandell, A. G., Inoue, S., Dennie, J. G., Nagasawa, Y., Gajee, R., Joe, P., Zhang, G., Zamora, C. A., Masuda, N., & Senaldi, G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02537-17 · Cited by 21
A Rapid, Accurate, Single Molecule Counting Method Detects Clostridium difficile Toxin B in Stool Samples
Gite, S., Archambault, D., Cappillino, M. P., Cunha, D., Dorich, V., Shatova, T. A., Tempesta, A., Walsh, B., Walsh, J. A., Williams, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26353-0 · Cited by 21
Environmental transmission of Clostridioides difficile ribotype 027 at a long-term care facility; an outbreak investigation guided by whole genome sequencing
Endres, B. T., Dotson, K. M., Poblete, K., McPherson, J. K., Lancaster, C. K., Bassères, E., Memariani, A., Arnold, S., Tupy, S., Carlsen, C., et al. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.230 · Cited by 21
Five years of fecal microbiota transplantation - an update of the Israeli experience
Greenberg, S. A., Youngster, I., Cohen, N. A., Livovsky, D. M., Strahilevitz, J., Israeli, E., Melzer, E., Paz, K., Isakov, N. F., & Maharshak, N. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i47.5403 · Cited by 21
Fecal microbiota transplantation in children: current concepts
Gurram, B., & Sue, P. K. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000787 · Cited by 21
Screening of Clostridioides difficile carriers in an urban academic medical center: Understanding implications of disease
Baron, S. W., Ostrowsky, B. E., Nori, P., Drory, D. Y., Levi, M. H., Szymczak, W. A., Rinke, M. L., & Southern, W. N. (2019) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2019.309 · Cited by 21
Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
Tijerina-Rodríguez, L., Villarreal-Treviño, L., Morfín‐Otero, R., Camacho-Ortíz, A., & Garza‐González, E. (2019) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2019/7127850 · Cited by 21
Coordinated modulation of multiple processes through phase variation of a c-di-GMP phosphodiesterase in Clostridioides difficile
Ruiz, L. M. R., King, K. A., Agosto‐Burgos, C., Gamez, I., Gadda, N. C., Garrett, E. M., & Tamayo, R. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010677 · Cited by 21
Clostridium difficile Infection Among US Emergency Department Patients With Diarrhea and No Vomiting
Abrahamian, F. M., Talan, D. A., Krishnadasan, A., Citron, D. M., Paulick, A. L., Anderson, L. J., Goldstein, E. J. C., Moran, G. J., Abrahamian, F. M., Moore, J., et al. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2016.12.013 · Cited by 21
A multicenter, retrospective, case‐cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients
Alonso, C. D., Braun, D. A., Patel, I. J., Akbari, M., Oh, D. J., Jun, T. W., McMasters, M., Hammond, S. P., Glotzbecker, B. E., Cutler, C. S., et al. (2017) · Transplant Infectious Disease · doi:10.1111/tid.12728 · Cited by 21
Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis
Burdet, C., Sayah-Jeanne, S., Nguyen, T. T., Miossec, C., Saint-Lu, N., Pulse, M., Weiss, W., Andremont, A., Mentré, F., & de Gunzburg, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-17 · Cited by 21
Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection
Davis, M. L., Sparrow, H. G., Ikwuagwu, J. O., Musick, W. L., Garey, K. W., & Perez, K. K. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.013 · Cited by 21
Recent advances in the treatment of C. difficile using biotherapeutic agents
Giau, V. V., Lee, H., An, S. S. A., & Hulme, J. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s207572 · Cited by 23
The effect of pulsed xenon ultraviolet light disinfection on healthcare-associated Clostridioides difficile rates in a tertiary care hospital
Attia, F., Whitener, C., Mincemoyer, S., Houck, J., & Julian, K. G. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2019.12.019 · Cited by 21
Incidence of public health surveillance-reported Clostridioides difficile infections in thirteen countries worldwide: A narrative review
Angulo, F. J., Furtado, M., Gonzalez, E., Zhang, P., Kelly, P. H., & Moïsi, J. C. (2024) · Anaerobe · doi:10.1016/j.anaerobe.2024.102878 · Cited by 20
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital
Pichenot, M., Héquette-Ruz, R., Guern, R. L., Grandbastien, B., Charlet, C., Wallet, F., Schiettecatte, S., Loeuillet, F., Guery, B. P., & Galperine, T. K. (2017) · Infection · doi:10.1007/s15010-017-0981-8 · Cited by 20
The adaptive immune response toClostridioides difficile: A tricky balance between immunoprotection and immunopathogenesis
Pino, R. E. H. D., Barbero, A. M., Español, L. Á., Morro, L. S., & Pasquinelli, V. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4vmr0720-201r · Cited by 20
Probabilistic transmission models incorporating sequencing data for healthcare-associated Clostridioides difficile outperform heuristic rules and identify strain-specific differences in transmission
Eyre, D. W., Laager, M., Walker, A. S., Cooper, B. S., Wilson, D. J., & (MInD-Healthcare), O. B. O. T. C. M. I. D. I. H. P. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008417 · Cited by 20
Computational modeling of the gut microbiota reveals putative metabolic mechanisms of recurrent Clostridioides difficile infection
Henson, M. A. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008782 · Cited by 19
Probiotics for kidney disease
Favero, C., Ortíz, A., & Sánchez-Niño, M. D. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac056 · Cited by 20
Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020
Okafor, C. M., Clogher, P., Olson, D. M., Niccolai, L. M., & Hadler, J. L. (2023) · Emerging infectious diseases · doi:10.3201/eid2905.221294 · Cited by 20
A dual-action antibiotic that kills Clostridioides difficile vegetative cells and inhibits spore germination
Janardhanan, J., Kim, C. K., Qian, Y., Yang, J., Meisel, J. E., Ding, D., Speri, E., Schroeder, V. A., Wolter, W. R., Oliver, A. G., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304110120 · Cited by 20
Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality
Patel, I. J., Wungjiranirun, M., Theethira, T. G., Villafuerte-Gálvez, J., Castillo, N., Akbari, M., Alonso, C. D., Leffler, D. A., & Kelly, C. P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw423 · Cited by 20
Recurrent Clostridium difficile infection among Medicare patients in nursing homes
Zilberberg, M. D., Shorr, A. F., Jesdale, B. M., Tjia, J., & Lapane, K. L. (2017) · Medicine · doi:10.1097/md.0000000000006231 · Cited by 20
Fecal Microbiota Transplantation for Refractory and RecurrentClostridium difficileInfection: A Case Series of Nine Patients
Bang, B. W., Park, J.-S., Kim, H. K., Shin, Y. W., Kwon, K. S., Kwon, H. Y., Baek, J. H., & Lee, J. S. (2017) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2017.69.4.226 · Cited by 20
Compliance with Clostridium difficile treatment guidelines: effect on patient outcomes
Crowell, K. T., Julian, K. G., Katzman, M., Berg, A. S., Tinsley, A., Williams, E., Koltun, W. A., & Messaris, E. (2017) · Epidemiology and Infection · doi:10.1017/s0950268817000644 · Cited by 20
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection
Prabhu, V. S., Cornely, O. A., Golan, Y., Dubberke, E. R., Heimann, S. M., Hanson, M. E., Liao, J., Pedley, A., Dorr, M. B., & Marcella, S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix523 · Cited by 20
Comparative epidemiology of Clostridium difficile infection: England and the USA
King, A., Mullish, B. H., Williams, H. R. T., & Aylin, P. P. (2017) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzx120 · Cited by 20
Genomic and phenotypic diversity of Clostridium difficile during long-term sequential recurrences of infection
Sachsenheimer, F. E., Yang, I., Zimmermann, O., Wrede, C., von Müller, L., Gunka, K., Groß, U., & Suerbaum, S. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.02.002 · Cited by 20
Clostridium difficile Screening for Colonization During an Outbreak Setting
Linsenmeyer, K. D., O’Brien, W., Brecher, S. M., Strymish, J. M., Rochman, A., Itani, K. M. F., & Gupta, K. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy455 · Cited by 20
Crystal Structures of R-Type Bacteriocin Sheath and Tube Proteins CD1363 and CD1364 From Clostridium difficile in the Pre-assembled State
Schwemmlein, N., Pippel, J., Gazdag, E. M., & Blankenfeldt, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01750 · Cited by 21
Development of Neutralizing and Non-neutralizing Antibodies Targeting Known and Novel Epitopes of TcdB of Clostridioides difficile
Fühner, V., Heine, P. A., Helmsing, S., Goy, S., Heidepriem, J., Loeffler, F. F., Dübel, S., Gerhard, R., & Hust, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02908 · Cited by 20
Long-Term Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infection in Patients With and Without Inflammatory Bowel Disease: A Tertiary Care Center’s Experience
Tabbaa, O. M., Aboelsoud, M. M., & Mattar, M. C. (2018) · Gastroenterology Research · doi:10.14740/gr1091 · Cited by 20
Clostridium difficile in Asia: Opportunities for One Health Management
Collins, D. A., & Riley, T. V. (2018) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed4010007 · Cited by 20
Long-Term Efficacy of Oral Vancomycin Prophylaxis for the Prevention of Clostridium difficile Recurrence
Knight, E. M., Schiller, D. S., Fulman, M., & Rastogi, R. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019825994 · Cited by 20
Reduced Clostridioides difficile Tests Among Solid Organ Transplant Recipients Through a Diagnostic Stewardship Bundled Intervention
Madden, G. R., & Sifri, C. D. (2019) · Annals of Transplantation · doi:10.12659/aot.915168 · Cited by 20
The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins
Erickson, S. L., Alston, L. A., Nieves, K., Chang, T. K. H., Mani, S., Flannigan, K. L., & Hirota, S. A. (2019) · The FASEB Journal · doi:10.1096/fj.201902083rr · Cited by 20
Non-Infection-Related And Non-Visit-Based Antibiotic Prescribing Is Common Among Medicaid Patients
Fischer, M. A., Mahesri, M., Lii, J., & Linder, J. A. (2020) · Health Affairs · doi:10.1377/hlthaff.2019.00545 · Cited by 20
Rapid in Vitro Assessment of Clostridioides difficile Inhibition by Probiotics Using Dielectrophoresis to Quantify Cell Structure Alterations
Moore, J. H., Honrado, C., Stagnaro, V., Kolling, G. L., Warren, C. A., & Swami, N. S. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00415 · Cited by 20
Peptidoglycan analysis reveals that synergistic deacetylase activity in vegetative Clostridium difficile impacts the host response
Coullon, H., Rifflet, A., Wheeler, R., Janoir, C., Boneca, I. G., & Candela, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012442 · Cited by 20
Prevalence, Colonization, Epidemiology, and Public Health Significance of Clostridioides difficile in Companion Animals
Hernandez, B. G., Vinithakumari, A. A., Sponseller, B. A., Tangudu, C. S., & Mooyottu, S. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.512551 · Cited by 20
Murine Intrarectal Instillation of Purified Recombinant Clostridioides difficile Toxins Enables Mechanistic Studies of Pathogenesis
Markham, N. O., Bloch, S. C., Shupe, J. A., Laubacher, E. N., Thomas, A. K., Kroh, H. K., Childress, K. O., Peritore‐Galve, F. C., Washington, M. K., Coffey, R. J., et al. (2021) · Infection and Immunity · doi:10.1128/iai.00543-20 · Cited by 20
Dissecting Individual Interactions between Pathogenic and Commensal Bacteria within a Multispecies Gut Microbial Community
Hassall, J., Cheng, J. K. J., & Unnikrishnan, M. (2021) · mSphere · doi:10.1128/msphere.00013-21 · Cited by 20
The Antimicrobial Stewardship Approach to Combating Clostridium Difficile
Wenzler, E., Mulugeta, S., & Danziger, L. H. (2015) · Antibiotics · doi:10.3390/antibiotics4020198 · Cited by 20
Editorial Commentary: The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance
Halpin, A. L., & McDonald, L. C. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw187 · Cited by 20
Self-citation
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank
Ianiro, G., Porcari, S., Bibbò, S., Giambò, F., Quaranta, G., Masucci, L., Sanguinetti, M., Gasbarrini, A., & Cammarota, G. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.04.009 · Cited by 19
Clostridium scindens: history and current outlook for a keystone species in the mammalian gut involved in bile acid and steroid metabolism
Daniel, S. L., & Ridlon, J. M. (2025) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf016 · Cited by 21
Characterisation of Clostridium difficile strains isolated from Groote Schuur Hospital, Cape Town, South Africa
Kullin, B., Brock, T. E., Rajabally, N., Anwar, F., Vedantam, G., Reid, S., & Abratt, V. R. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2717-6 · Cited by 19
Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure
Lee, C., Chai, J., Hammond, K., Jeon, S. R., Patel, Y. S., Goldeh, C., & Kim, P. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03602-2 · Cited by 19
Clinical impact of pharmacist-led antibiotic stewardship programs in outpatient settings in the United States: A scoping review
Louis, J. S., & Okere, A. N. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab178 · Cited by 19
Binding and neutralization of C. difficile toxins A and B by purified clinoptilolite-tuff
Ranftler, C., Nagl, D., Sparer, A., Röhrich, A., Freissmuth, M., El‐Kasaby, A., Nasrollahi-Shirazi, S., Koban, F., Tschegg, C., & Nizet, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252211 · Cited by 19
Genetically related Clostridium difficile from water sources and human CDI cases revealed by whole‐genome sequencing
Lim, S., Hain‐Saunders, N. M. R., Imwattana, K., Putsathit, P., Collins, D. A., & Riley, T. V. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15821 · Cited by 19
Diversity, Dynamics and Therapeutic Application of Clostridioides difficile Bacteriophages
Nale, J. Y., Thanki, A. M., Rashid, S. J., Shan, J., Vinner, G. K., Dowah, A. S. A., Cheng, J. K. J., Sicheritz‐Pontén, T., & Clokie, M. R. J. (2022) · Viruses · doi:10.3390/v14122772 · Cited by 19
Practical Use of RBX2660 for the Prevention of Recurrent Clostridioides difficile Infection
Feuerstadt, P., Allegretti, J. R., & Khanna, S. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002195 · Cited by 19
Update on Commonly Used Molecular Typing Methods for Clostridioides difficile
Abad-Fau, A., Sevilla, E., Martín‐Burriel, I., Moreno, B., & Bolea, R. (2023) · Microorganisms · doi:10.3390/microorganisms11071752 · Cited by 20
Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review
Gilboa, M., Baharav, N., Melzer, E., Regev‐Yochay, G., & Yahav, D. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00856-4 · Cited by 19
Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia
Yang, T., Li, G., Xu, Y., He, X., Song, B., & Cao, Y. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03329-x · Cited by 20
Fecal transplantation - the new, inexpensive, safe, and rapidly effective approach in the treatment of gastrointestinal tract diseases.
Opriţă, R., Bratu, M. R., Opriță, B., & Diaconescu, B. I. (2016) · PubMed Central · Cited by 19
Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile
Duvall, J. R., Bedard, L. L., Naylor-Olsen, A. M., Manson, A. L., Bittker, J. A., Sun, W., Fitzgerald, M. E., He, Z., Lee, M. D., Marié, J., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00206 · Cited by 19
The Attributable Burden of Clostridium difficile Infection to Long‐Term Care Facilities Stay: A Clinical Study
Karanika, S., Grigoras, C. A., Flokas, M. E., Alevizakos, M., Kinamon, T., Kojic, E. M., & Mylonakis, E. E. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14863 · Cited by 19
Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving Antibiotics
Shen, N. T., Leff, J. A., Schneider, Y., Crawford, C. V., Maw, A., Bosworth, B. P., & Simon, M. S. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx148 · Cited by 21
Healthcare-Associated Clostridium difficile Infections are Sustained by Disease from the Community
McLure, A., Clements, A., Kirk, M., & Glass, K. (2017) · Bulletin of Mathematical Biology · doi:10.1007/s11538-017-0328-8 · Cited by 19
Significant Publications on Infectious Diseases Pharmacotherapy in 2016
Fong, G. R., Skoglund, E. W., Phe, K., Guastadisegni, J. M., Shea, K. M., McDaneld, P. M., Perez, K. K., & Sofjan, A. K. (2017) · Journal of Pharmacy Practice · doi:10.1177/0897190017727212 · Cited by 19
Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?
Allegretti, J. R., Kassam, Z., & Chan, W. W. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4864-8 · Cited by 19
Immunization Strategies Against Clostridium difficile
Bruxelle, J.-F., Péchiné, S., & Collignon, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-72799-8_12 · Cited by 19
Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan
Tokimatsu, I., Shigemura, K., Osawa, K., Kinugawa, S., Kitagawa, K., Nakanishi, N., Yoshida, H., Arakawa, S., & Fujisawa, M. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.03.015 · Cited by 19
Identification of large cryptic plasmids in Clostridioides (Clostridium) difficile
Amy, J., Bulach, D., Knight, D. R., Riley, T., Johanesen, P., & Lyras, D. (2018) · Plasmid · doi:10.1016/j.plasmid.2018.04.001 · Cited by 19

Authors: Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., Wilson, L. E., Winston, L. G., Cohen, J. A., Limbago, B. M., Fridkin, S. K., Gerding, D. N., & McDonald, L. C.
Affiliations: National Center for Emerging and Zoonotic Infectious Diseases (US)
Colorado Department of Public Health and Environment (US)
Oregon Health Authority (US)
University of Rochester Medicine (US)
Tennessee Department of Health (US)
Emory University (US)
Office of Readiness and Response (US)
Yale University (US)
University of New Mexico (US)
Maryland Department of Health (US)
University of California, San Francisco (US)
Loyola University Chicago (US)
ORCID: Lessa, Fernanda C.
Mu, Yi
Bamberg, Wendy M.
Dumyati, Ghinwa K.
Dunn, John R.
Farley, Monica M.
Holzbauer, Stacy M.
Meek, James I.
Phipps, Erin C.
Wilson, Lucy E.
Fridkin, Scott K.
Gerding, Dale N.
McDonald, L. Clifford
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-02-26
Volume: 372
Issue: 9
Pages: 825-834
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1408913
PMC: PMC10966662
OpenAlex: W2071054182
Cited by: 2,641
References: 44
Citations by year: 2026: 94 · 2025: 111 · 2024: 120 · 2023: 150 · 2022: 176 · 2021: 225 · 2020: 328 · 2019: 382 · 2018: 356 · 2017: 323 · 2016: 262 · 2015: 108
FWCI: 270.42
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: other-oa
Locations: New England Journal of Medicine (publishedVersion, other-oa)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Maryland Shared Open Access Repository (USMAI Consortium) (submittedVersion, public-domain)
eScholarship (California Digital Library) (submittedVersion)
Digital Repository at the University of Maryland (University of Maryland College Park) (public-domain)
Funders: National Institutes of Health (CC999999)
Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords: Clostridium difficile infection, incidence, nosocomial infections, community-associated infections, recurrence, mortality, NAP1 strain, molecular typing, pulsed-field gel electrophoresis
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Clostridium Infections, Cross Infection, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Recurrence, United States, Bacterial Typing Techniques, Incidence, Clostridioides difficile, Electrophoresis, Gel, Pulsed-Field, Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Burden of Clostridium difficile Infection in the United States

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks